Physician

Daniel C. Dapprich, M.D.

According to 2025 Medicare claims, Daniel Dapprich, M.D. (NPI: 1578549242) practices dermatology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is DAWM, PLC (NPI: 1932132446; TIN: 383516038) and primary practice location at 49546-8622.

Dapprich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,135 traditional Medicare patients, billed 4,139 HCPCS/CPT codes, and received $210,350 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 2,153 prescription claims across 820 beneficiaries totaling $978,043 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 13 records totaling $282. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $208,471 to $978,043. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,113	5,461	$237,840
2016	1,063	5,246	$231,522
2017	1,158	5,247	$230,262
2018	1,289	5,396	$254,325
2019	1,320	5,433	$251,819
2020	1,201	5,281	$246,391
2021	1,288	4,850	$243,466
2022	1,384	5,144	$256,770
2023	1,212	4,281	$217,795
2024	1,135	4,139	$210,350

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	517	1,250	$208,471
2016	514	1,368	$185,885
2017	546	1,410	$148,621
2018	589	1,530	$257,277
2019	614	1,599	$275,048
2020	683	1,792	$372,217
2021	807	2,101	$426,956
2022	846	2,204	$599,497
2023	838	2,294	$830,145
2024	820	2,153	$978,043

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	158	176	$63
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	407	458	$56
88305	Pathology examination of tissue using a microscope, intermediate complexity	789	1,452	$52
17000	Destruction of precancer skin growth, 1 growth	156	174	$34
17003	Destruction of precancer skin growth, 2-14 growths	109	529	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	14	1,008	$264,895
Humira(Cf) Pen	Adalimumab	23	644	$227,591
Dupixent Pen	Dupilumab	27	784	$103,536
Adbry	Tralokinumab-Ldrm	15	420	$63,047
Fluorouracil	Fluorouracil	107	3,767	$6,119

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$282	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel C. Dapprich, M.D.?

Tedicare shows public-source Medicare data for Daniel C. Dapprich, M.D. (NPI 1578549242), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel C. Dapprich, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Daniel C. Dapprich, M.D.?

Daniel C. Dapprich, M.D. is linked to DAWM, PLC (billing NPI 1932132446) in the available physician profile data.

Does Daniel C. Dapprich, M.D. have Open Payments data?

Daniel C. Dapprich, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.